Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

Published in:

PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189848

By:

• O’Neil, Bert H.;
• Wallmark, John M.;
• Lorente, David;
• Elez, Elena;
• Raimbourg, Judith;
• Gomez-Roca, Carlos;
• Ejadi, Samuel;
• Piha-Paul, Sarina A.;
• Stein, Mark N.;
• Abdul Razak, Albiruni R.;
• Dotti, Katia;
• Santoro, Armando;
• Cohen, Roger B.;
• Gould, Marlena;
• Saraf, Sanatan;
• Stein, Karen;
• Han, Sae-Won

Publication type:

Article